Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

With Friends Like These: The Complex Role of Neutrophils in the Progression of Severe Pneumonia.

Pechous RD.

Front Cell Infect Microbiol. 2017 May 1;7:160. doi: 10.3389/fcimb.2017.00160. eCollection 2017. Review.

2.

Early application of low-dose glucocorticoid improves acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.

Yang ZG, Lei XL, Li XL.

Exp Ther Med. 2017 Apr;13(4):1215-1224. doi: 10.3892/etm.2017.4154. Epub 2017 Feb 22.

3.

Using cluster analysis of cytokines to identify patterns of inflammation in hospitalized patients with community-acquired pneumonia: a pilot study.

Wiemken TL, Kelley RR, Fernandez-Botran R, Mattingly WA, Arnold FW, Furmanek SP, Restrepo MI, Chalmers JD, Peyrani P, Cavallazzi R, Bordon J, Aliberti S, Ramirez JA.

Univ Louisville J Respir Infect. 2017;1(1):3-11. doi: 10.18297/jri/vol1/iss1/1/. Epub 2017 Jan 30.

4.

Corticosteroids in septic shock: a systematic review and network meta-analysis.

Gibbison B, López-López JA, Higgins JP, Miller T, Angelini GD, Lightman SL, Annane D.

Crit Care. 2017 Mar 28;21(1):78. doi: 10.1186/s13054-017-1659-4.

5.

Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis.

Bi J, Yang J, Wang Y, Yao C, Mei J, Liu Y, Cao J, Lu Y.

PLoS One. 2016 Nov 15;11(11):e0165942. doi: 10.1371/journal.pone.0165942. eCollection 2016. Review.

6.

Clinical Practice Guideline of Acute Respiratory Distress Syndrome.

Cho YJ, Moon JY, Shin ES, Kim JH, Jung H, Park SY, Kim HC, Sim YS, Rhee CK, Lim J, Lee SJ, Lee WY, Lee HJ, Kwak SH, Kang EK, Chung KS, Choi WI; Korean Society of Critical Care Medicine; Korean Academy of Tuberculosis and Respiratory Diseases Consensus Group.

Tuberc Respir Dis (Seoul). 2016 Oct;79(4):214-233. Epub 2016 Oct 5. Review. Erratum in: Tuberc Respir Dis (Seoul). 2017 Jan;80(1):95.

7.

Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial.

Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU.

Crit Care. 2016 Oct 15;20(1):329.

8.

New aspects in the management of pneumonia.

Prina E, Ceccato A, Torres A.

Crit Care. 2016 Oct 1;20(1):267. Review.

9.

Severe community-acquired pneumonia: timely management measures in the first 24 hours.

Phua J, Dean NC, Guo Q, Kuan WS, Lim HF, Lim TK.

Crit Care. 2016 Aug 28;20:237. doi: 10.1186/s13054-016-1414-2. Review.

10.

Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us.

Schwingshackl A, Meduri GU.

Front Pediatr. 2016 Jun 14;4:58. doi: 10.3389/fped.2016.00058. eCollection 2016. Review.

11.
12.

Acute respiratory distress syndrome caused by Mycoplasma pneumoniae without elevated pulmonary vascular permeability: a case report.

Takahashi N, Shinohara T, Oi R, Ota M, Toriumi S, Ogushi F.

J Thorac Dis. 2016 May;8(5):E319-24. doi: 10.21037/jtd.2016.03.08.

13.

Adjuvant corticosteroids for patients hospitalized with community-acquired pneumonia: is it time?

Revest M, Egmann G, Chapron A, Jouneau S, Tattevin P.

J Thorac Dis. 2016 May;8(5):E288-91. doi: 10.21037/jtd.2016.03.34. No abstract available.

14.

The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.

Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, Marshall JC, Cook DJ, Jouvet P, Ferguson ND, Griesdale D, Burry LD, Burns KE, Hutchison J, Mehta S, Menon K, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative.

Crit Care. 2016 Mar 30;20:75. doi: 10.1186/s13054-016-1230-8.

15.

Advances in the prevention, management, and treatment of community-acquired pneumonia.

Pletz MW, Rohde GG, Welte T, Kolditz M, Ott S.

F1000Res. 2016 Mar 8;5. pii: F1000 Faculty Rev-300. doi: 10.12688/f1000research.7657.1. eCollection 2016. Review.

16.

Epidemiology, Seasonality and Treatment of Hospitalized Adults and Adolescents with Influenza in Jingzhou, China, 2010-2012.

Zheng J, Huo X, Huai Y, Xiao L, Jiang H, Klena J, Greene CM, Xing X, Huang J, Liu S, Peng Y, Yang H, Luo J, Peng Z, Liu L, Chen M, Chen H, Zhang Y, Huang D, Guan X, Feng L, Zhan F, Hu DJ, Varma JK, Yu H.

PLoS One. 2016 Mar 9;11(3):e0150713. doi: 10.1371/journal.pone.0150713. eCollection 2016.

17.

Systemic corticosteroids and community-acquired pneumonia-cautious optimism or wishful thinking?

Waterer G.

J Thorac Dis. 2015 Dec;7(12):E622-4. doi: 10.3978/j.issn.2072-1439.2015.12.22. No abstract available.

18.

Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis.

Marti C, Grosgurin O, Harbarth S, Combescure C, Abbas M, Rutschmann O, Perrier A, Garin N.

PLoS One. 2015 Dec 7;10(12):e0144032. doi: 10.1371/journal.pone.0144032. eCollection 2015. Review.

19.

Corticosteroids for severe CAP: the pros.

Torres A.

Rev Bras Ter Intensiva. 2015 Jul-Sep;27(3):202-4. doi: 10.5935/0103-507X.20150041. English, Portuguese. No abstract available.

20.

Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: A meta-analysis of randomized controlled trials.

Chen LP, Chen JH, Chen Y, Wu C, Yang XH.

World J Emerg Med. 2015;6(3):172-8. doi: 10.5847/wjem.j.1920-8642.2015.03.002.

Supplemental Content

Support Center